InvestorsHub Logo
Followers 14
Posts 898
Boards Moderated 0
Alias Born 03/07/2011

Re: None

Thursday, 06/09/2011 6:21:18 AM

Thursday, June 09, 2011 6:21:18 AM

Post# of 20689
How can TEVA lie this blatantly?

The US Food and Drug Administration (FDA) has postponed a ruling on the Citizens Petition of Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA; TASE:TEVA) to prevent the launching of generic Copaxone. A company spokesman told "Globes" that the FDA decision has been put off to an unspecified date.
Teva was responding to a report on "Fly on the Wall" yesterday that the FDA had dismissed the company's petition regarding Copaxone, Teva's flagship multiple sclerosis treatment.

http://www.globes.co.il/serveen/globes/docview.asp?did=1000652722&fid=1725